Mineralys Therapeutics, Inc. (MLYS)
25.40
-0.27
(-1.05%)
USD |
NASDAQ |
Sep 01, 10:10
Mineralys Therapeutics Net Income (TTM) : -349.58M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -349.58M |
| March 31, 2026 | -151.78M |
| December 31, 2025 | -154.65M |
| September 30, 2025 | -171.36M |
| June 30, 2025 | -190.77M |
| March 31, 2025 | -188.51M |
| December 31, 2024 | -177.81M |
| September 30, 2024 | -153.25M |
| Date | Value |
|---|---|
| June 30, 2024 | -119.67M |
| March 31, 2024 | -90.80M |
| December 31, 2023 | -71.90M |
| September 30, 2023 | -56.58M |
| June 30, 2023 | -40.50M |
| March 31, 2023 | -34.84M |
| December 31, 2022 | -29.80M |
| September 30, 2022 | -27.81M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| MapLight Therapeutics, Inc. | -229.83M |
| Evommune, Inc. | -94.67M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |